Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF – Get Free Report) was up 69.9% on Tuesday . The stock traded as high as $16.00 and last traded at $16.00. Approximately 200 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 400 shares. The stock had previously closed at $9.42.
Santhera Pharmaceuticals Price Performance
The firm has a fifty day simple moving average of $9.81 and a two-hundred day simple moving average of $10.70.
About Santhera Pharmaceuticals
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).
Featured Stories
- Five stocks we like better than Santhera Pharmaceuticals
- How to Use Stock Screeners to Find Stocks
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What Are the FAANG Stocks and Are They Good Investments?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Santhera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santhera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
